AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2014

Jun 27, 2014

Director's Dealing

Opens in your device viewer

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2014-06-18

Reporting Person: Varvaro Thomas C (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-18	Employee Stock Options (right to buy)	$1.25	A	125000	Acquired	2024-06-18	Common Stock (125000)	Direct

F1: Options vest 25% on June 18, 2015 with the remainder vesting 1/36th per month over three years thereafter.

F2: The total includes 1,904,499 options under different terms.